Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes
The aim of this study was to prospectively investigate 120 cases of viridans streptococcal bacteraemia (VSB) in 117 patients in major university hospitals in Slovakia in 2000-2002 (3 y) for antibacterial susceptibility, risk factors and outcome. From 127 episodes, 16 (13%) of VSB were caused by PEN-...
Gespeichert in:
| Veröffentlicht in: | Scandinavian journal of infectious diseases 2005, Vol.37 (9), p.637-641 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 641 |
|---|---|
| container_issue | 9 |
| container_start_page | 637 |
| container_title | Scandinavian journal of infectious diseases |
| container_volume | 37 |
| creator | Mrazova, M. Docze, A. Buckova, E. Bucko, L. Kacmarikova, M. Grey, E. Korcova, J. Koprnova, J. Saboova, Z. Beno, P. Karvaj, M. Svetlansky, I. Ondrus, A. Benca, J. Taziarova, M. Rudinsky, B. Krcmery, V. |
| description | The aim of this study was to prospectively investigate 120 cases of viridans streptococcal bacteraemia (VSB) in 117 patients in major university hospitals in Slovakia in 2000-2002 (3 y) for antibacterial susceptibility, risk factors and outcome. From 127 episodes, 16 (13%) of VSB were caused by PEN-R strains and 13 (10%) by ERY-R strains. 32 cases had cancer as underlying disease (20 haematological), 41 had endocarditis and 35 were elderly (>65 y of age) patients. Concerning mortality, 29 of 127 patients died (24%). There were several risk factors associated with mortality. Solid tumour as underlying disease (p |
| doi_str_mv | 10.1080/00365540510043266 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_1080_00365540510043266</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68525041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-4d4171a1c5306364967faa2e380150911bc03a4588d2e852dc03c794961186833</originalsourceid><addsrcrecordid>eNqFks1u1DAUhS0EotOBB2CDvIEVgXvj2HEEG1TxU6lSWcA6uuM4qksSB9uZat6Ax66HGVQhpHZl2ec7R_fHjL1AeIug4R2AUFJWIBGgEqVSj9gKlcQCGw2P2WqvFxnQJ-w0xmvIlBLwlJ2gwlJJVa7Y72_Bx9ma5LaWT5Scn2jgcQlbu-O-51sXXEdT5DEFOydvvDEZ2JBJNpAdHfHg4k_e5wcf4htOU3IH1f0Jiibb3MYNLu2y2HG_JONHuw_HEridXfSdjc_Yk56GaJ8fzzX78fnT97OvxcXll_OzjxeFqZRMRdVVWCOhkQKUUFWj6p6otEIDSmgQNwYEVVLrrrRall2-mrrJHKJWWog1e33InYP_tdiY2tHlGoeBJuuX2KpsklDhgyA2taoznEE8gCaPMgbbt3NwI4Vdi9Du99T-t6fseXkMXzaj7e4cx8Vk4NURoJgH3geajIt3XA21rHM_a_bhwLmp92GkGx-Grk20G3z4axL31fH-H_uVpSFdGQq2vfZLyH8h3tPFLclIwGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19767852</pqid></control><display><type>article</type><title>Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes</title><source>MEDLINE</source><source>Taylor & Francis:Master (3349 titles)</source><source>Taylor & Francis Medical Library - CRKN</source><creator>Mrazova, M. ; Docze, A. ; Buckova, E. ; Bucko, L. ; Kacmarikova, M. ; Grey, E. ; Korcova, J. ; Koprnova, J. ; Saboova, Z. ; Beno, P. ; Karvaj, M. ; Svetlansky, I. ; Ondrus, A. ; Benca, J. ; Taziarova, M. ; Rudinsky, B. ; Krcmery, V.</creator><creatorcontrib>Mrazova, M. ; Docze, A. ; Buckova, E. ; Bucko, L. ; Kacmarikova, M. ; Grey, E. ; Korcova, J. ; Koprnova, J. ; Saboova, Z. ; Beno, P. ; Karvaj, M. ; Svetlansky, I. ; Ondrus, A. ; Benca, J. ; Taziarova, M. ; Rudinsky, B. ; Krcmery, V.</creatorcontrib><description><![CDATA[The aim of this study was to prospectively investigate 120 cases of viridans streptococcal bacteraemia (VSB) in 117 patients in major university hospitals in Slovakia in 2000-2002 (3 y) for antibacterial susceptibility, risk factors and outcome. From 127 episodes, 16 (13%) of VSB were caused by PEN-R strains and 13 (10%) by ERY-R strains. 32 cases had cancer as underlying disease (20 haematological), 41 had endocarditis and 35 were elderly (>65 y of age) patients. Concerning mortality, 29 of 127 patients died (24%). There were several risk factors associated with mortality. Solid tumour as underlying disease (p<0.02), stroke (p<0.002), concomitant lung infection (p<0.01), endoscopic procedure (p<0.036), intubation (p<0.0008), ventilatory support (p<0.002), and coma (p<0.009) were associated with more deaths. A comparison of 115 bacteraemias to 13 bacteraemias caused by erythromycin-resistant strains of Streptococcus viridans was performed. There were no significant differences in underlying disease, risk factors and mortality. Erythromycin resistance in bacteraemias caused by S. viridans did not have significant impact on outcome of the patients, nor did it show specific relation to analysed risk factors in our study. 14.5% of VSB were cause by PEN-resistant viridans streptococci. Risk factors for penicillin resistance were ventilatory support (p<0.01), intubation (p<0.001) and resistance to other antibiotics: 8 of 16 (50%) of PEN-R VSB were resistant also to erythromycin or cotrimoxazole or tetracycline compared with 9% of PEN-R VSB (p<0.005). Endoscopic procedures in the upper respiratory system were at risk for development of PEN-R VSB. There was also difference in outcome; 71% vs 22.5% (p<0.0002) of cases infected with PEN-R VSB died compared to PEN-S VSB. PEN-R is therefore clinically significant in VSB.]]></description><identifier>ISSN: 0036-5548</identifier><identifier>EISSN: 1651-1980</identifier><identifier>DOI: 10.1080/00365540510043266</identifier><identifier>PMID: 16126562</identifier><identifier>CODEN: SJIDB7</identifier><language>eng</language><publisher>Basingstoke: Informa UK Ltd</publisher><subject>Aged ; Anti-Bacterial Agents - pharmacology ; Bacteremia - complications ; Bacteremia - microbiology ; Bacteremia - mortality ; Bacterial diseases ; Bacterial sepsis ; Biological and medical sciences ; Child, Preschool ; Drug Resistance, Bacterial ; Erythromycin - pharmacology ; Health Surveys ; Human bacterial diseases ; Humans ; Infectious diseases ; Medical sciences ; Microbial Sensitivity Tests ; Penicillin Resistance ; Prospective Studies ; Risk Factors ; Slovakia ; Staphylococcal infections, streptococcal infections, pneumococcal infections ; Streptococcal Infections - complications ; Streptococcal Infections - microbiology ; Streptococcal Infections - mortality ; Streptococcus ; Streptococcus viridans ; Viridans Streptococci - drug effects ; Viridans Streptococci - isolation & purification ; Viridans Streptococci - pathogenicity</subject><ispartof>Scandinavian journal of infectious diseases, 2005, Vol.37 (9), p.637-641</ispartof><rights>2005 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2005</rights><rights>2005 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-4d4171a1c5306364967faa2e380150911bc03a4588d2e852dc03c794961186833</citedby><cites>FETCH-LOGICAL-c465t-4d4171a1c5306364967faa2e380150911bc03a4588d2e852dc03c794961186833</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/00365540510043266$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/00365540510043266$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,780,784,4023,27922,27923,27924,59646,59752,60435,60541,61220,61255,61401,61436</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17075768$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16126562$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mrazova, M.</creatorcontrib><creatorcontrib>Docze, A.</creatorcontrib><creatorcontrib>Buckova, E.</creatorcontrib><creatorcontrib>Bucko, L.</creatorcontrib><creatorcontrib>Kacmarikova, M.</creatorcontrib><creatorcontrib>Grey, E.</creatorcontrib><creatorcontrib>Korcova, J.</creatorcontrib><creatorcontrib>Koprnova, J.</creatorcontrib><creatorcontrib>Saboova, Z.</creatorcontrib><creatorcontrib>Beno, P.</creatorcontrib><creatorcontrib>Karvaj, M.</creatorcontrib><creatorcontrib>Svetlansky, I.</creatorcontrib><creatorcontrib>Ondrus, A.</creatorcontrib><creatorcontrib>Benca, J.</creatorcontrib><creatorcontrib>Taziarova, M.</creatorcontrib><creatorcontrib>Rudinsky, B.</creatorcontrib><creatorcontrib>Krcmery, V.</creatorcontrib><title>Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes</title><title>Scandinavian journal of infectious diseases</title><addtitle>Scand J Infect Dis</addtitle><description><![CDATA[The aim of this study was to prospectively investigate 120 cases of viridans streptococcal bacteraemia (VSB) in 117 patients in major university hospitals in Slovakia in 2000-2002 (3 y) for antibacterial susceptibility, risk factors and outcome. From 127 episodes, 16 (13%) of VSB were caused by PEN-R strains and 13 (10%) by ERY-R strains. 32 cases had cancer as underlying disease (20 haematological), 41 had endocarditis and 35 were elderly (>65 y of age) patients. Concerning mortality, 29 of 127 patients died (24%). There were several risk factors associated with mortality. Solid tumour as underlying disease (p<0.02), stroke (p<0.002), concomitant lung infection (p<0.01), endoscopic procedure (p<0.036), intubation (p<0.0008), ventilatory support (p<0.002), and coma (p<0.009) were associated with more deaths. A comparison of 115 bacteraemias to 13 bacteraemias caused by erythromycin-resistant strains of Streptococcus viridans was performed. There were no significant differences in underlying disease, risk factors and mortality. Erythromycin resistance in bacteraemias caused by S. viridans did not have significant impact on outcome of the patients, nor did it show specific relation to analysed risk factors in our study. 14.5% of VSB were cause by PEN-resistant viridans streptococci. Risk factors for penicillin resistance were ventilatory support (p<0.01), intubation (p<0.001) and resistance to other antibiotics: 8 of 16 (50%) of PEN-R VSB were resistant also to erythromycin or cotrimoxazole or tetracycline compared with 9% of PEN-R VSB (p<0.005). Endoscopic procedures in the upper respiratory system were at risk for development of PEN-R VSB. There was also difference in outcome; 71% vs 22.5% (p<0.0002) of cases infected with PEN-R VSB died compared to PEN-S VSB. PEN-R is therefore clinically significant in VSB.]]></description><subject>Aged</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Bacteremia - complications</subject><subject>Bacteremia - microbiology</subject><subject>Bacteremia - mortality</subject><subject>Bacterial diseases</subject><subject>Bacterial sepsis</subject><subject>Biological and medical sciences</subject><subject>Child, Preschool</subject><subject>Drug Resistance, Bacterial</subject><subject>Erythromycin - pharmacology</subject><subject>Health Surveys</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Penicillin Resistance</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Slovakia</subject><subject>Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><subject>Streptococcal Infections - complications</subject><subject>Streptococcal Infections - microbiology</subject><subject>Streptococcal Infections - mortality</subject><subject>Streptococcus</subject><subject>Streptococcus viridans</subject><subject>Viridans Streptococci - drug effects</subject><subject>Viridans Streptococci - isolation & purification</subject><subject>Viridans Streptococci - pathogenicity</subject><issn>0036-5548</issn><issn>1651-1980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks1u1DAUhS0EotOBB2CDvIEVgXvj2HEEG1TxU6lSWcA6uuM4qksSB9uZat6Ax66HGVQhpHZl2ec7R_fHjL1AeIug4R2AUFJWIBGgEqVSj9gKlcQCGw2P2WqvFxnQJ-w0xmvIlBLwlJ2gwlJJVa7Y72_Bx9ma5LaWT5Scn2jgcQlbu-O-51sXXEdT5DEFOydvvDEZ2JBJNpAdHfHg4k_e5wcf4htOU3IH1f0Jiibb3MYNLu2y2HG_JONHuw_HEridXfSdjc_Yk56GaJ8fzzX78fnT97OvxcXll_OzjxeFqZRMRdVVWCOhkQKUUFWj6p6otEIDSmgQNwYEVVLrrrRall2-mrrJHKJWWog1e33InYP_tdiY2tHlGoeBJuuX2KpsklDhgyA2taoznEE8gCaPMgbbt3NwI4Vdi9Du99T-t6fseXkMXzaj7e4cx8Vk4NURoJgH3geajIt3XA21rHM_a_bhwLmp92GkGx-Grk20G3z4axL31fH-H_uVpSFdGQq2vfZLyH8h3tPFLclIwGw</recordid><startdate>2005</startdate><enddate>2005</enddate><creator>Mrazova, M.</creator><creator>Docze, A.</creator><creator>Buckova, E.</creator><creator>Bucko, L.</creator><creator>Kacmarikova, M.</creator><creator>Grey, E.</creator><creator>Korcova, J.</creator><creator>Koprnova, J.</creator><creator>Saboova, Z.</creator><creator>Beno, P.</creator><creator>Karvaj, M.</creator><creator>Svetlansky, I.</creator><creator>Ondrus, A.</creator><creator>Benca, J.</creator><creator>Taziarova, M.</creator><creator>Rudinsky, B.</creator><creator>Krcmery, V.</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>2005</creationdate><title>Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes</title><author>Mrazova, M. ; Docze, A. ; Buckova, E. ; Bucko, L. ; Kacmarikova, M. ; Grey, E. ; Korcova, J. ; Koprnova, J. ; Saboova, Z. ; Beno, P. ; Karvaj, M. ; Svetlansky, I. ; Ondrus, A. ; Benca, J. ; Taziarova, M. ; Rudinsky, B. ; Krcmery, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-4d4171a1c5306364967faa2e380150911bc03a4588d2e852dc03c794961186833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aged</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Bacteremia - complications</topic><topic>Bacteremia - microbiology</topic><topic>Bacteremia - mortality</topic><topic>Bacterial diseases</topic><topic>Bacterial sepsis</topic><topic>Biological and medical sciences</topic><topic>Child, Preschool</topic><topic>Drug Resistance, Bacterial</topic><topic>Erythromycin - pharmacology</topic><topic>Health Surveys</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Penicillin Resistance</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Slovakia</topic><topic>Staphylococcal infections, streptococcal infections, pneumococcal infections</topic><topic>Streptococcal Infections - complications</topic><topic>Streptococcal Infections - microbiology</topic><topic>Streptococcal Infections - mortality</topic><topic>Streptococcus</topic><topic>Streptococcus viridans</topic><topic>Viridans Streptococci - drug effects</topic><topic>Viridans Streptococci - isolation & purification</topic><topic>Viridans Streptococci - pathogenicity</topic><toplevel>online_resources</toplevel><creatorcontrib>Mrazova, M.</creatorcontrib><creatorcontrib>Docze, A.</creatorcontrib><creatorcontrib>Buckova, E.</creatorcontrib><creatorcontrib>Bucko, L.</creatorcontrib><creatorcontrib>Kacmarikova, M.</creatorcontrib><creatorcontrib>Grey, E.</creatorcontrib><creatorcontrib>Korcova, J.</creatorcontrib><creatorcontrib>Koprnova, J.</creatorcontrib><creatorcontrib>Saboova, Z.</creatorcontrib><creatorcontrib>Beno, P.</creatorcontrib><creatorcontrib>Karvaj, M.</creatorcontrib><creatorcontrib>Svetlansky, I.</creatorcontrib><creatorcontrib>Ondrus, A.</creatorcontrib><creatorcontrib>Benca, J.</creatorcontrib><creatorcontrib>Taziarova, M.</creatorcontrib><creatorcontrib>Rudinsky, B.</creatorcontrib><creatorcontrib>Krcmery, V.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mrazova, M.</au><au>Docze, A.</au><au>Buckova, E.</au><au>Bucko, L.</au><au>Kacmarikova, M.</au><au>Grey, E.</au><au>Korcova, J.</au><au>Koprnova, J.</au><au>Saboova, Z.</au><au>Beno, P.</au><au>Karvaj, M.</au><au>Svetlansky, I.</au><au>Ondrus, A.</au><au>Benca, J.</au><au>Taziarova, M.</au><au>Rudinsky, B.</au><au>Krcmery, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes</atitle><jtitle>Scandinavian journal of infectious diseases</jtitle><addtitle>Scand J Infect Dis</addtitle><date>2005</date><risdate>2005</risdate><volume>37</volume><issue>9</issue><spage>637</spage><epage>641</epage><pages>637-641</pages><issn>0036-5548</issn><eissn>1651-1980</eissn><coden>SJIDB7</coden><abstract><![CDATA[The aim of this study was to prospectively investigate 120 cases of viridans streptococcal bacteraemia (VSB) in 117 patients in major university hospitals in Slovakia in 2000-2002 (3 y) for antibacterial susceptibility, risk factors and outcome. From 127 episodes, 16 (13%) of VSB were caused by PEN-R strains and 13 (10%) by ERY-R strains. 32 cases had cancer as underlying disease (20 haematological), 41 had endocarditis and 35 were elderly (>65 y of age) patients. Concerning mortality, 29 of 127 patients died (24%). There were several risk factors associated with mortality. Solid tumour as underlying disease (p<0.02), stroke (p<0.002), concomitant lung infection (p<0.01), endoscopic procedure (p<0.036), intubation (p<0.0008), ventilatory support (p<0.002), and coma (p<0.009) were associated with more deaths. A comparison of 115 bacteraemias to 13 bacteraemias caused by erythromycin-resistant strains of Streptococcus viridans was performed. There were no significant differences in underlying disease, risk factors and mortality. Erythromycin resistance in bacteraemias caused by S. viridans did not have significant impact on outcome of the patients, nor did it show specific relation to analysed risk factors in our study. 14.5% of VSB were cause by PEN-resistant viridans streptococci. Risk factors for penicillin resistance were ventilatory support (p<0.01), intubation (p<0.001) and resistance to other antibiotics: 8 of 16 (50%) of PEN-R VSB were resistant also to erythromycin or cotrimoxazole or tetracycline compared with 9% of PEN-R VSB (p<0.005). Endoscopic procedures in the upper respiratory system were at risk for development of PEN-R VSB. There was also difference in outcome; 71% vs 22.5% (p<0.0002) of cases infected with PEN-R VSB died compared to PEN-S VSB. PEN-R is therefore clinically significant in VSB.]]></abstract><cop>Basingstoke</cop><pub>Informa UK Ltd</pub><pmid>16126562</pmid><doi>10.1080/00365540510043266</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0036-5548 |
| ispartof | Scandinavian journal of infectious diseases, 2005, Vol.37 (9), p.637-641 |
| issn | 0036-5548 1651-1980 |
| language | eng |
| recordid | cdi_informahealthcare_journals_10_1080_00365540510043266 |
| source | MEDLINE; Taylor & Francis:Master (3349 titles); Taylor & Francis Medical Library - CRKN |
| subjects | Aged Anti-Bacterial Agents - pharmacology Bacteremia - complications Bacteremia - microbiology Bacteremia - mortality Bacterial diseases Bacterial sepsis Biological and medical sciences Child, Preschool Drug Resistance, Bacterial Erythromycin - pharmacology Health Surveys Human bacterial diseases Humans Infectious diseases Medical sciences Microbial Sensitivity Tests Penicillin Resistance Prospective Studies Risk Factors Slovakia Staphylococcal infections, streptococcal infections, pneumococcal infections Streptococcal Infections - complications Streptococcal Infections - microbiology Streptococcal Infections - mortality Streptococcus Streptococcus viridans Viridans Streptococci - drug effects Viridans Streptococci - isolation & purification Viridans Streptococci - pathogenicity |
| title | Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A15%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prospective%20national%20survey%20of%20viridans%20streptococcal%20bacteraemia%20risk%20factors,%20antibacterial%20susceptibility%20and%20outcome%20of%20120%20episodes&rft.jtitle=Scandinavian%20journal%20of%20infectious%20diseases&rft.au=Mrazova,%20M.&rft.date=2005&rft.volume=37&rft.issue=9&rft.spage=637&rft.epage=641&rft.pages=637-641&rft.issn=0036-5548&rft.eissn=1651-1980&rft.coden=SJIDB7&rft_id=info:doi/10.1080/00365540510043266&rft_dat=%3Cproquest_infor%3E68525041%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19767852&rft_id=info:pmid/16126562&rfr_iscdi=true |